Stonepine Capital Management »

Alexandria Real Estate Equities shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Alexandria Real Estate Equities (ARE) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Alexandria Real Estate Equities

Tip: Access up to 7 years of quarterly data

All positions including Alexandria Real Estate Equities held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alexandria Real Estate Equities by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4M 50k 48.94

More positions owned by Stonepine Capital Management

Verastem Com New (VSTM)
Adma Biologics (ADMA)
Evolus (EOLS)
Nektar Therapeutics Com New Call Option (NKTR)
Zevra Therapeutics Com New (ZVRA)
Inhibikase Therapeutics Com New (IKT)
Abeona Therapeutics Com New Call Option (ABEO)
Indivior Ord
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Kazia Therapeutics Sponsored Ads (KZIA)
Xoma Royalty Corporation Com New (XOMA)
Verrica Pharmaceuticals Com Shs (VRCA)
Cybin Com New (HELP)
Tela Bio (TELA)
ACADIA Pharmaceuticals (ACAD)

View all positions for Stonepine Capital Management

Top funds holding Alexandria Real Estate Equities

Vanguard Group
BlackRock
Norges Bank Investment Management
State Street Corporation
APG Asset Management US
Invesco
Geode Capital Management
Capital World Investors
Goldman Sachs Group
Jpmorgan Chase & Co
Northern Trust
AQR Capital Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Susquehanna International

View all funds holding Alexandria Real Estate Equities